Peptide therapy for increasing platelet levels
AssigneeBiokine Therapeutics Ltd.
InventorsMichal Abraham, Amnon Peled, Orly Eizenberg
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel therapeutic uses of T-140 analog peptides and compositions comprising same. Specifically, the invention relates to compositions and methods for providing improved platelet levels, useful in the treatment and prevention of thrombocytopenia, for controlling bleeding and for inducing or modulating haemostasis.
Claims6
A method for transiently elevating the levels of platelets in peripheral blood of a thrombocytopenic human subject in need thereof, comprising administering to the human subject an effective amount of a peptide of an amino acid sequence as set forth in SEQ ID NO:1 so as to transiently elevate the levels of platelets in the thrombocytopenic human subject.
Dependencies are inferred from the claim text.